Search
There’s a More Humane Way to Monitor Crohn's and Colitis Patients
IBD, which comprises Crohn’s disease and ulcerative colitis, affects 1.3% of the U.S. population and accounts for 3 million new diagnoses every year.Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
New data from a clinical trial show therapies may activate lymph nodes to produce tumor-tackling T cells.Personalizing Prostate Cancer Screening May Improve the Accuracy of Detection
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer.UCSF’s First Medical Director of Robotic Surgery on Improving Patient Outcomes and Enabling Innovation
Thoracic surgeon Johannes Kratz, MD, has been selected as UCSF’s first medical director of robotic surgery.UCSF’s Division of Cardiology to Partner with Rosenman Institute
UC San Francisco’s Division of Cardiology has joined with the Rosenman Institute to speed the development of health-tech innovation at UCSF.New ATS Recommendation: Use Race-Neutral Equations for Pulmonary Function Test Interpretation to Improve Patient Care
An American Thoracic Society (ATS) workshop committee, which included many UCSF researchers, recently released an official statement recommending the use of race-neutral average reference equations for pulmonary function test (PFT) interpretation.First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.The Fetal Treatment Center in Oakland: Expanded Services, Informed Strategies - Intro
Learn which patients may benefit from referral and what to expect from the process in this update from perinatologist Annalisa Post, MD.Advanced Heart Failure Clinic at Walnut Creek
Through a collaboration between John Muir Health and UCSF Health, patients with advanced heart failure have access to specialized care in Walnut Creek.Alcohol-Associated Liver Disease Program
UCSF HEPATOLOGY AND LIVER TRANSPLANT SERVICES have established the Alcohol-Associated Liver Disease Program, expanding access to hepatology care and liver transplantation for a broader range of patients.Preeclampsia Update: How to Identify and Manage a Perilous Pregnancy Complication
This important talk from Annalisa Post, MD, a perinatologist with the UCSF Fetal Treatment Center, clarifies the definition of preeclampsia, lays out risk factors, and elucidates the tricky business of recognizing worsening hypertension in pregnancy.Interventional Cardiology Program
The UCSF Interventional Cardiology Program offers the latest minimally invasive catheter-based procedures to diagnose and treat the full spectrum of cardiovascular conditions.Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer Patients
Led by a multidisciplinary team of specialists and researchers, our program optimizes the cardiovascular health of cancer patients and cancer survivors.Keys to the Knees: How to Approach a Variety of Meniscus Tears
Historically misunderstood even by sports medicine specialists, meniscus tears are a range of conditions best managed by considering specifics of both the injury and the patient.Halt the UTI Cycle: Tips and Techniques for Treating a Common Urinary Woe
Urogynecologist Abigail Shatkin-Margolis, MD, offers an update to help PCPs efficiently assess and treat patients prone to urinary tract infections, with a focus on both young and elderly adults.The Reflux “Cycle of Hell”: An ENT Perspective on Setting Patients Free
When different doctors – PCPs, gastroenterologists and otolaryngologists – take different approaches to the common problem of acid reflux, patients often continue to suffer.A Fresh Look at Lipids: Atherosclerosis Prevention in 2023
Cardiologist Clifton Watt, MD, presents an update on lipoproteins, including how genetic factors can impact test results and whether pre-measurement fasting actually matters.Focused Cancer Updates: Neoadjuvant Therapy for Breast Cancer and Managing Immunotherapy Toxicity
An expert panel delivers news to inform therapy and monitoring decisions, including a look at how the I-SPY 2 trial is accelerating evaluation of promising agents in high-risk breast cancer.Novel Tricuspid and Mitral Valve Procedures Improve Patients' Quality of Life
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.The UCSF Hip Preservation Center: Where Hurting Hips Go to Become Happy Hips
See how our specialists work together and use advanced techniques to address all types of hip injuries in all types of patients, including infants and athletes.Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find
Patients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.Susceptibility to Pathogenic T Cells in Chronic Lung Disease May have a Genetic Basis
Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common diagnoses for hospital admissions.Chances of Receiving Percutaneous Coronary Intervention in a Low-Volume Facility are Increasing, Despite Worse Outcomes
There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes.UCSF Surgical Oncologists Present Clinical Findings at International Conference
The latest advances in surgical cancer care and research were showcased at the Society of Surgical Oncology’s (SSO) Annual Meeting, the International Conference on Surgical Cancer Care. The meeting was held in Boston, from March 22 – 25, 2023.